bpc-157 human case report study The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and Safety BPC-157 General Info Sheet
Description
Insulin-like growth factor-I stimulates both cell growth and lipogenesis during differentiation of human mesenchymal stem cells into adipocytes
While that gap is meaningful, it was not dramatic enough for AOD-9604 to win approval as a standalone obesity drug, and formal development was paused in 2007

Most available studies focus on short-to-medium-term healing outcomes, typically spanning several weeks to a few months

[DOI] [PubMed] [Google Scholar] 297.Tlak Gajger I., Smodi kerl M.I., otari P., uran J., Sikiri P., Vlaini J

Additional injections of 100 mcg monthly may be needed depending on level of symptom improvement and cause of vitamin B12 deficiency

Indicated especially when neurological signs or severe anemia are present
